We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
- Authors
Rai, K R; Freter, C E; Mercier, R J; Cooper, M R; Mitchell, B S; Stadtmauer, E A; Santábarbara, P; Wacker, B; Brettman, L
- Abstract
This phase II pilot study determined the efficacy and safety of alemtuzumab (Campath-1H; Burroughs Wellcome, United Kingdom) in patients with chronic lymphocytic leukemia (CLL), all of whom had previously received fludarabine and other chemotherapy regimens.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Vol 20, Issue 18, p3891
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2002.06.119